Please select the option that best describes you:

Do more fractionated regimens reduce severe toxicity over SBRT in patients with ILD and early-stage NSCLC?  



Answer from: Radiation Oncologist at Community Practice
Comments
Radiation Oncologist at Paramount Oncology Group
Very interesting. Thank you for this insight!
Radiation Oncologist at Rush University Medical Center
I offer here the following comment about treating ...
Radiation Oncologist at UCLA | VA Greater Los Angeles Healthcare System
@Ross, once again, you offer sage words of advice....
Sign in or Register to read more

Answer from: Radiation Oncologist at Community Practice
Sign in or Register to read more